| Date | Time | Source | Headline | Symbol | Company |
| 02/12/2024 | 7:24PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 02/12/2024 | 7:24PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 02/12/2024 | 7:24PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 02/12/2024 | 7:24PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 02/12/2024 | 4:19PM | Edgar (US Regulatory) | Form 3/A - Initial statement of beneficial ownership of securities: [Amend] | NYSE:JNJ | Johnson and Johnson |
| 02/12/2024 | 4:10PM | Business Wire | Johnson & Johnson to Participate in the Leerink Global Biopharma Conference | NYSE:JNJ | Johnson and Johnson |
| 02/09/2024 | 12:55PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:JNJ | Johnson and Johnson |
| 02/09/2024 | 12:35PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:JNJ | Johnson and Johnson |
| 02/06/2024 | 4:24PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:JNJ | Johnson and Johnson |
| 02/02/2024 | 5:07PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:JNJ | Johnson and Johnson |
| 02/02/2024 | 4:52PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:JNJ | Johnson and Johnson |
| 02/02/2024 | 4:10PM | Business Wire | Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference | NYSE:JNJ | Johnson and Johnson |
| 01/29/2024 | 4:50PM | Edgar (US Regulatory) | Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | NYSE:JNJ | Johnson and Johnson |
| 01/26/2024 | 11:49AM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:JNJ | Johnson and Johnson |
| 01/24/2024 | 12:51PM | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NYSE:JNJ | Johnson and Johnson |
| 01/24/2024 | 6:06AM | IH Market News | Wall Street Highlights: eBay Slashes 9% of Workforce, SAP to Reduce 8,000 Positions, and More | NYSE:JNJ | Johnson and Johnson |
| 01/23/2024 | 10:18AM | Dow Jones News | Trending: Johnson & Johnson 4Q Tops Views; Talc Settlement Near | NYSE:JNJ | Johnson and Johnson |
| 01/23/2024 | 7:45AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:JNJ | Johnson and Johnson |
| 01/23/2024 | 7:10AM | Dow Jones News | Johnson & Johnson 4Q Sales Beat Expectations Led by U.S. Growth | NYSE:JNJ | Johnson and Johnson |
| 01/23/2024 | 6:20AM | Business Wire | Johnson & Johnson Reports Q4 and Full-Year 2023 Results | NYSE:JNJ | Johnson and Johnson |
| 01/23/2024 | 5:40AM | IH Market News | Wall Street Highlights: Vroom Shuts Down Online Car Sales, Ericsson Warns of Decline Outside China, and More | NYSE:JNJ | Johnson and Johnson |
| 01/11/2024 | 6:18AM | IH Market News | Wall Street Highlights: Mastercard’s Financial Rise, Citigroup’s $3.8 Billion Charges, and More | NYSE:JNJ | Johnson and Johnson |
| 01/09/2024 | 5:08PM | Edgar (US Regulatory) | Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | NYSE:JNJ | Johnson and Johnson |
| 01/09/2024 | 6:12AM | IH Market News | Wall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and More | NYSE:JNJ | Johnson and Johnson |
| 01/08/2024 | 5:22PM | Edgar (US Regulatory) | Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material | NYSE:JNJ | Johnson and Johnson |
| 01/08/2024 | 2:54PM | Dow Jones News | Trending: Johnson & Johnson and Merck & Co. Announce Acquisitions | NYSE:JNJ | Johnson and Johnson |
| 01/08/2024 | 11:09AM | Dow Jones News | Johnson & Johnson to Settle States' Talc Probe for $700 Million, Bloomberg Reports | NYSE:JNJ | Johnson and Johnson |
| 01/08/2024 | 10:04AM | Dow Jones News | Ambrx Biopharma Shares Double on $2 Billion Acquisition by Johnson & Johnson | NYSE:JNJ | Johnson and Johnson |
| 01/08/2024 | 8:22AM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NYSE:JNJ | Johnson and Johnson |
| 01/08/2024 | 8:12AM | Dow Jones News | Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2 Billion | NYSE:JNJ | Johnson and Johnson |